NeuroOne’s Cortical Electrode Cleared by FDA

The FDA issued 510(k) clearance for NeuroOne’s Evo thin film cortical electrode, a device used to temporarily stimulate, monitor and record brain activity.

This thin film technology “offers the potential for improved resolution during recording brain activity, future placement through a less invasive procedure, and reduced inflammation of brain tissue,” the company said.

NeuroOne plans to apply its cortical electrode technology to other devices for use with therapeutic applications for Parkinson’s disease, epilepsy and for spinal cord stimulation.